R1 Announces Appointment of Agnes Bundy Scanlan to Board of Directors
MURRAY, Utah, Aug. 12, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that...
Month: August 2021
BioCardia Reports Second Quarter 2021 Financial Results and Business Highlights
SAN CARLOS, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- BioCardia, Inc. , a developer of cellular and cell-derived therapeutics for the...
F-star Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Company to Host Conference Call Today at 9 a.m. EDTCAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Aug. 12, 2021 (GLOBE NEWSWIRE)...
Selecta Biosciences Reports Second Quarter 2021 Financial Results and Provides Business Update
IND filing for wholly owned gene therapy program, SEL-302 (MMA-101, in combination with ImmTOR) in methylmalonic acidemia (MMA) expected during...
Healthwise and TCS Healthcare Technologies Join Forces to Achieve Better Health Outcomes
Partnership will reduce cost, ensure appropriate care, and help people better navigate their health care experiencesBOISE, Idaho, Aug. 12, 2021...
BiomX to Host Second Quarter 2021 Financial Results Conference Call and Webcast on August 16, 2021
NESS ZIONA, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage...
Pharma Two B Appoints Jeffrey Berkowitz as Chairman of its Board of Directors
REHOVOT, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Pharma Two B Ltd., a privately held company developing innovative therapeutics based...
Awakn Life Sciences Begins Trading on the OTCQB(R) Venture Market Under the Symbol ‘AWKNF’ on August 12th
Toronto, Ontario--(Newsfile Corp. - August 12, 2021) - Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) ('Awakn'), a biotechnology company...
NextGen Healthcare Announces Date for 2021 Annual Meeting of Shareholders
ATLANTA--(BUSINESS WIRE)--$NXGN #NextGenHealthcare--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, will hold its 2021 Annual Meeting...
CORRECTING and REPLACING Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit
SANTA BARBARA, Calif.--(BUSINESS WIRE)--Presentation time in the release dated August 2, 2021, should read 8:00 am PT on Thursday, August...
Emerald Health Therapeutics Comments on Board Resignation
Vancouver, British Columbia--(Newsfile Corp. - August 11, 2021) - Further to its press release of August 6th, Emerald Health Therapeutics,...
Defence Therapeutics Receives DTC Eligibility
Vancouver, British Columbia--(Newsfile Corp. - August 11, 2021) - Defence Therapeutics Inc. (CSE: DTC) ("Defence" or the "Company"), a biotechnology...
KORU Medical Systems Announces 2021 Second Quarter Financial Results
CHESTER, N.Y.--(BUSINESS WIRE)--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical...
StageZero to Issue Q2 2021 Financial Results and Hold Conference Call on Tuesday, August 17
TORONTO, ON / ACCESSWIRE / August 11, 2021 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that...
Achieve Reports Financial Results for Second Quarter 2021 and Provides Corporate Update
SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / August 12, 2021 / Achieve Life Sciences, Inc. (Nasdaq:ACHV), a clinical-stage pharmaceutical...
Cloud DX to Host Earnings Webcast Tuesday August 17th, 2021
WATERLOO, ON / ACCESSWIRE / August 11, 2021 / Cloud DX (TSXV:CDX)(OTCQB:CDXFF), (the 'Company') a leading North American provider of...
Next Science Begins U.S. Clinical Trial for XPERIENCE No Rinse Antimicrobial Solution
Highlights Clinical trial for XPERIENCE commences after receiving FDA clearance in April Randomized, controlled, double-blinded study will evaluate the effects...
Sorrento and Dyadic Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate “DYAI-100” and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics
Sorrento to obtain exclusive rights in North and South America, Europe, major Asian countries (including Greater China and Japan) and...
Vyant Bio Announces Investor Conference Call and Webcast for Second Quarter 2021
CHERRY HILL, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug...
Creo appoints commercial leader Graeme Kenny as Chief Revenue Officer
Creo appoints commercial leader Graeme Kenny as Chief Revenue Officer Head of Croda Personal Care in North America joins Creo...